Article Text

Download PDFPDF
Jejunal ischaemia following inferior mesenteric artery angioembolisation for type 2 endoleak
  1. Hester Lacey1,
  2. Roger Gill1,
  3. Dhiraj Joshi2 and
  4. Mario Caruana1
  1. 1Department of Vascular Surgery, University Hospitals Sussex NHS Foundation Trust, Brighton, UK
  2. 2Department of Radiology, University Hospitals Sussex NHS Foundation Trust, Brighton, UK
  1. Correspondence to Dr Hester Lacey; hesterlacey{at}


We present a rare case of short-segment jejunal infarction following inferior mesenteric artery embolisation for type 2 endoleak in a patient who previously underwent endovascular repair of abdominal aortic aneurysm. Potential causes for the event might include thromboembolism or traumatic thrombosis of a jejunal branch of the superior mesenteric artery (SMA) caused by a buddy guide wire used to maintain the position of the long vascular sheath in the SMA hiatus. The condition was recognised on CT and treated with resection of the infarcted segment of the small bowel followed by primary anastomosis.

  • Vascular surgery
  • Interventional radiology

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors The following authors were responsible for drafting the text, sourcing and editing clinical images, investigating results, drawing original diagrams and algorithms, and critically revising important intellectual content: HL, RG, MC and DJ. The following authors gave final approval of the manuscript: HL, RG, MC and DJ.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.